LSPedia has launched a pilot program to develop improved solutions and processes for DSCSA exceptions management in the supply chain, joined by participants and observers from all across the prescription drug supply chain. This program is designed to achieve system-agnostic, actionable findings on the complex data errors that can halt the flow of product any time it changes hands.
Exceptions are data errors that occur when a shipped product can’t be accepted due to incorrect data, missing data, missing product, or discrepancies with the shipment. Such errors are already inevitable in DSCSA implementation, more so because EPCIS data exchanges are new to many trading partners. These errors can halt product movement, add complexity, and increase staff workloads, boosting labor and costs. The delays they cause can keep medicines from reaching patients.
After November 27, 2023, data will need to accompany product every time it changes hands. This will create an explosion in EPCIS file exchanges, from 5,000 per day to 500,000 and beyond – and exceptions will increase right along with them.To prevent these disruptions, LSPediA is building on its leadership in exceptions management with an industry pilot program designed to foster deep understanding of new problem scenarios before they can occur widely, and discussing the solutions, procedures, and best practices that will keep prescription drugs moving through the supply chain.
This pilot provides agnostic exceptions solutions for the entire supply chain, along with targeted processes and procedures for different business types. It covers a range of issues with EPCIS data, data exchanges, and logistics, incorporating the exceptions categories found in HDA’s “Exceptions Guidelines for the DSCSA.” These include product without data, data without product, packaging or labeling problems, and other discrepancies.
The group is compiling a comprehensive list of error scenarios and design methods to resolve them. From there, it will develop metrics to evaluate each method, reach consensus on how they should be applied, and recommend best practices.
Qualified participants are manufacturers, wholesale distributors, dispensers, and healthcare providers, including both LSPediA customers and non-customers.Pilot members will meet twice monthly to discuss current outcomes, identify new exceptions, propose solutions to issues that have been discovered, and exchange ideas and practical business needs related to exceptions management. This group meets on Wednesdays at 2PM ET. The program is expected to conclude in May 2023.
Experience and resolve real-life scenarios created by the industry's leading companies.
Get the full hands-on experience using real EPCIS data.
Gain insight into processes and best practices through open discussions with key industry leaders.
The pilot program provides participants with live EPCIS exceptions resolutions, giving them valuable insights into how to resolve real-world supply chain issues. This hands-on approach to testing and refining helps ensure that the resolutions will be effective, efficient, and easily implementable for companies of all sizes.
This pilot is designed to identify, discuss, and resolve various exceptions scenarios that are used to created Standard Operating Procedures. Participants will receive these SOPs at the conclusion of the pilot.
.webp){kind=logo}
.svg){kind=icon}
